Neutrophil to lymphocyte ratio (NLR) as a predictor of poor prognosis in advanced non-small cell lung cancer
Hela Cherif (Tunis, Tunisia), Hela Cherif, Saoussen Bacha, Amani Sghaier, Sonia Habibech, Hager Racil, Sana Cheikhrouhou, Naouel Chaouech, Abdellatif Chabbou, Mohamed Lamine Megdiche
|   |
The prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with non-small cell lung cancer
Pınar Yıldız (Istanbul, Turkey), Pinar Yildiz, Mesut Bayraktaroglu
| |
Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment
Joanna Domagała-Kulawik (Warsaw, Poland), Iwona Osinska, Anna Stelmaszczyk-Emmel, Malgorzata Proboszcz, Malgorzata Polubiec-Kownacka, Dariusz Dziedzic, Joanna Domagala-Kulawik
| |
Feroptosis of alveolar macrophages in lung cancer
Svetlana Zunic (Beograd, Republic of Serbia), Svetlana Zunic, Snezana Zunic
| |
CD163 and CCR7 markers for macrophage polarisation in patients with lung cancer
Joanna Domagała-Kulawik (Warsaw, Poland), Iwona Osinska, Dominika Wolosz, Malgorzata Proboszcz, Malgorzata Polubiec-Kownacka, Dariusz Dziedzic, Joanna Domagala-Kulawik
| |
Interleukin 27 (IL27) as antitumor tool? Results from bronchoalveolar lavage (BAL) examination
Joanna Woźniak (Bydgoszcz, Poland), Joanna Wozniak, Tomasz Wandtke, Joanna Chorostowska-Wynimko, Teresa Iwaniec, Cezary Rybacki, Blazej Przybyslawski, Piotr Kopinski
| |
Pro and anti-inflammatory cytokines in patients with lung adenocarcinoma clinical stages IIIB and IV undergoing chemotherapy
Uriel Rumbo Nava (Mexico, Mexico), Uriel Rumbo Nava, José Sullivan López González, Lorenzo Islas Vázquez, Renata Alejandra Báez Saldaña
| |
Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Saoussen Bacha (Ariane/Tunis, Tunisia), Saoussen Bacha, Sabrine Mejdoub, Amani Sghaier, Habibach Sonia, Hager Racil, Sana Cheikhrouhou, Naouel Chaouch, Abdellatif Chabbou, Mohamed Lamine Megdiche
| |
COPD-like inflammation drives the progression of K-ras induced early cancerous lesions
Christopher Jungnickel (Homburg, Germany), Christopher Jungnickel, Philipp Schnabel, Rainer Bohle, Robert Bals, Christoph Beisswenger
| |
The oppositedirection of LC3 A/B-I/II change in Raw264.7 cells and A549 cells treated with graphene oxide and its functionalized chemicals
Jong-Wook Shin (Seoul, Republic of Korea), Jong-Wook Shin, Jae Woo Jung, Jae Chul Choi, Jae Yeol Kim, In Won Park, Byoung Whui Choi, Chang Seok Park, Kyoung Soon Choi, Soo Young Kim
| |
cAMP-response element binding protein in KRAS-driven lung adenocarcinoma
Georgia Giotopoulou (Patra, Greece), Georgia Giotopoulou, Nikolitsa Spiropoulou, Evanthia Tourkochristou, Ioannis Lilis, Nikolaos Kanellakis, Anthodesmi Krontira, Georgios Stathopoulos, Antonia Marazioti
| |
Bone marrow-derived mesenchymal stem cells involve in lymphangiogenesis of lung cancer
Xian-Mei Zhou (Nanjing, China), Xian-Mei Zhou, Dan Wang, Jie Tang
| |
Dihydroartemisinin combined with cisplatinum induced apoptosis and related mechanism research in human lung adenocarcinoma H1299 cells
Xiao-Bo Yin (Qinhuangdao, China), Xiao-Bo Yin, Ping Wang, Yue Zheng, Shu-Feng Xu, Ai-Min Li, Jing Zhao, Fei-Fei Liu, Qi Tian
| |
CellCollector®: A novel method for the isolation of circulating tumor cells (CTC) in vivo and ex vivo in lung cancer patients during therapy
Bernd Schmidt (Halle, Germany), Bernd Schmidt, Hubertus Rolke, Clemens Oerding, Michael Fleischhacker
| |